Establishment Labs Holdings Inc (ESTA)

A look at the shareholders of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) can tell us which group is most...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the launch of JOY™, a new patient-centric breast aesthetics program. Women who select JOY will receive Establishment Labs’ newest generation Motiva Ergonomix2® implants through a network of highly trained plastic surgeons as well as the most comprehensive patient support program available in the industry. JOY is being unveiled at the 6th World Symposium on Ergonomic Implants that is being attended by over 200 plastic surgeons this week in Gardone Riviera, Italy.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the events and activities planned for the month of October in support of Pink October and Breast Cancer Awareness Month.

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares MSCI USA Small-Cap Multifactor ETF (SMLF), we found that the implied analyst target price for the ETF based upon its underlying holdings is $63.57 per unit.

In trading on Tuesday, shares of Establishment Labs Holdings Inc (ESTA) crossed below their 200 day moving average of $66.11, changing hands as low as $65.76 per share. Establishment Labs Holdings Inc shares are currently trading down about 3.8% on the day..

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, held a symposium at the London Breast Meeting on Thursday, September 2, 2021, marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it will host an event on September 2, 2021 marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries. Motiva Flora offers several notable advances, including Establishment Labs’ patented SmoothSilk® surface technology as well as an RFID enabled non-magnetic integrated port, that offer potential improvements in imaging, treatment, and overall clinical outcomes and patient satisfaction.

SANTA BARBARA, Calif., August 20, 2021--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it will host an event on September 2, 2021 marking the official launch of the company’s Motiva Flora® tissue expander in Europe and other CE Mark countries. Motiva Flora offers several notable advances, including Establishment Labs’ patented SmoothSilk®

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Presentation time in the release dated August 2, 2021, should read 8:00 am PT on Thursday, August 12, 2021 (instead of 8 am ET).

Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading ...

Gaeta, a seasoned medical technology executive joins the company as it continues its product and healthcare market expansion

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 21.43% and 1.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2021 and provided updated 2021 guidance.

On Thursday, July 29, Establishment Labs Hldgs (NASDAQ:ESTA) will release its latest earnings report. Check out Benzinga's preview to ...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced publication of its 2020 Corporate Social Responsibility annual review to coincide with the third anniversary of the company’s public listing on NASDAQ.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2021, before the market opens on Thursday, July 29, 2021, and will host a conference call at 8:30 am ET that day to discuss those results.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the appointment of Ann Custin and Bryan Slotkin to its Board of Directors, effective immediately.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Renee Gaeta will step down from her position as Chief Financial Officer for another opportunity outside of the company, effective July 30, 2021 and following the planned release of the company’s second quarter financial results. Raj Denhoy, Head of Strategy and Investor Relations, has been named Interim Chief Financial Officer effective upon Mrs. Gaeta’s departure.

Establishment Labs Holdings Inc. (ESTA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today held the groundbreaking ceremony for its new Sulayöm Innovation Campus in Costa Rica. When complete, the new facilities will total approximately 145,000 square feet (13,500 square meters) and will support the company’s continued global growth with additional capacity and capabilities in manufacturing, R&D, digital media, training, and medical education.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced results from a landmark study investigating how different breast implant surfaces affect the host immune response. The purpose of the study was to determine the optimal breast implant surface topography that induces the least amount of adverse foreign-body response and understand better how breast implant design impacts biocompatibility.

While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Heather Brennan has joined the company as Head of U.S. Commercial Operations and Neeta Toprani has joined as General Counsel & Corporate Secretary.

Tuesday's morning session saw 173 companies set new 52-week highs. Significant Points: The largest ...

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 1-4, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 2:00 pm ET on Friday, June 4, 2021.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Pratip Dastidar has been appointed Head of Global Operations.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the UBS Global Healthcare Virtual Conference, which is being held May 24-26, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:00 am ET on Monday, May 24, 2021.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.

Establishment Labs Hldgs (NASDAQ:ESTA) releases its next round of earnings this Wednesday, May 05. Here is Benzinga's essential guide to ...